Patients prescribed tiotropium for COPD treatment should follow up regularlyÂ with their prescribing provider to monitor adverse effects and obstructive lung disease progression. Although tiotropium demonstrates poor absorption across the pulmonary capillaries for systemic circulation, the development of urinary retention and narrow-angle glaucoma have occurred as adverse effects resulting in dysuria and permanent vision damage, respectively.